老和病是两笔账:把年龄从疾病里剥出来,谐波谱还剩几分解释力

Written by

in

Language

Evidence level: B

一个 65 岁的健康人和一个 45 岁但患糖尿病 10 年的人,脉象可能长得很像。可”老了”和”病了”是两笔完全不同的账——分不开,前面所有”硬化→谐波谱”的结论就都建在混账上。

正文

上一篇把”硬化/后负荷”摆上了台面:脉象谐波谱里有相当一部分方差能被 PWV(脉搏波传导速度)和 AIx(增强指数)解释。但那个结论有个致命默认前提——PWV 和 AIx 的变化,是年龄带来的,还是疾病带来的?

这不是学术洁癖。Framingham 子代队列(188 男 333 女,排除临床心血管病、高血压、糖尿病、吸烟与肥胖)显示,“年龄增长”就是颈股 PWV 升高的最主要相关因素,模型 R²=0.512(PMID 15123572)。连高血压糖尿病都剔干净的纯净样本里,硬化照样随年龄涨。所以拿年轻人当健康组去比老年人的糖尿病组,测到的”糖尿病致硬化”里有一大块只是”糖尿病组平均更老”。

更麻烦的是,这种混淆不是加性偏移,而是斜率被改写。Cameron 等在 169 人(糖尿病 57、非糖尿病 112)里测三段动脉 PWV,糖尿病组 PWV 更快、中心动脉顺应性更低(0.662 vs 0.850,P<0.05),但平均年龄比对照组小 10 岁;且校正血压后糖尿病组的 PWV 与年龄根本不再相关(PMID 12832325)。作者称之为”在更早的年龄加速老化,随后到达功能平台”——在糖尿病人群里”年龄→硬化”那条回归线是平的,把他们的 PWV 代进健康人参照表算”血管年龄”,生理上没有意义。

那两者各占多少?Alecu 等在 221 名 60 岁以上表观健康者里做多变量回归,PWV 与年龄、男性、平均动脉压、糖尿病各自独立相关(PMID 16855622)。”独立”说明统计上分得开,但和”分得干净”差得远——两者共享同一条下游通路(弹性蛋白断裂、胶原交联、糖基化终产物堆积)。

2023 年一项系统综述纳入 167 项研究、509,743 人、34 国,给出 PWV 的年龄-性别参照值(PMID 37229905):同一个 PWV,不同年龄性别地区意义完全不同(亚洲 baPWV 比欧洲高 1.83 m/s,P=0.0014)。任何绝对阈值,不分层就是错的。

问题于是精确化:控制年龄后,PWV/AIx 对谐波谱的解释力还剩多少?糖尿病和高血压是否携带独立于硬化的谐波信号? 三种结局都是知识:

结局一(缩水):ΔR² 掉到 5% 以下——此前关联的主体是年龄在冒充硬化,”谐波谱读血管硬度”须降级为”读血管年龄”。
结局二(保留):ΔR² 保持 15% 以上且 VIF<3,则”硬化独立于年龄改写谐波谱”站得住,可再拆 AIx 管哪几阶、PWV 管哪几阶。
结局三(疾病带独立信号):控制年龄与 PWV 后糖尿病或高血压组仍在特定阶次偏移——最值钱的一格,意味着谐波谱里存在硬化解释不了的疾病指纹,可能来自微循环阻力、自主神经张力或血黏度。”同病异脉、异病同脉”的物理落点正在这里。

坑一:拿”血管年龄”当协变量。 血管年龄本身从 PWV 和年龄算出,拿它当协变量等于把要分离的东西混回去。必须用原始 PWV + 年龄两个独立协变量。

坑二:年龄分层后样本塌方。 老年组糖尿病患病率天然更高,严格分层后某些格子只剩几个人。替代方案是按年龄性别 BMI 血压心率做倾向性评分 1:1 匹配,或把年龄做成限制性立方样条(年龄与硬化的关系明确非线性,Uejima 等在 1847 名健康者里测得年龄解释颈动脉弹性模量 53% 变异,斜率在老年段显著变陡)。

坑三:把”未解释残差”读成”疾病指纹”。 控制年龄和 PWV 后仍有差异,只说明”不是这两者解释的”,不说明”是糖尿病本身”——可能是用药、活动量、肾功能连带。要主张特异性,须在同病不同并发症内部做剂量-反应检验。一个已被证伪的乐观想法值得记下:既然都走硬化通路,直接测 PWV 不就完了?数据不支持。Tomita 等在 194 名 2 型糖尿病者里逐步回归,径向 AI 的独立决定因素是平均血压(β=0.260)、心率(β=−0.550)、身高(β=−0.217),HbA1c 多因素后不再显著(PMID 18497469)。Wilhelm 等的 33 名糖尿病者 AIx 高于对照(21.12% vs 19.84%)但未达显著,而 100 名非糖尿病心血管病者显著升高(26.00%,P<0.02)(PMID 19888415)。“糖尿病”这个标签本身对波形形状的解释力,弱得出乎意料。

年龄的顽固性则有生理落点。Davies 等把主动脉内增强压力拆成前向波/后向反射波/储器压力三份,发现计入储器后后向反射波贡献被削掉 64%,储器压力成为最大成分且随年龄递增 9.9 mmHg/十年(r=0.69,P<0.001),后向波与年龄不再相关(PMID 20008272)。年龄改写波形的主通道是主动脉储器容量,不是反射波提前返回——只控 PWV 会漏掉这一路,这就是要同时收 AIx 和 PWV 的原因。

最后一个隐患:传递函数误差会被当成生理信号。Papaioannou 等在 103 人里模拟校准误差,肱动脉收缩压单独偏 ±5 mmHg 时有 76% 原样传到反推的中心动脉压,而平均压>117 mmHg 或心率<74 bpm 者传递比例更高(PMID 16229910)。老年人糖尿病人恰是血压更高、心率更慢那一档——误差传递率最高的正是要比较的两组。故本设计强制同设备同校准,并优先用实测桡动脉波形做谐波分解。

四步设计:① 全样本类型 III 方差分解,谐波能量比(C1-C10)为因变量,年龄/性别/PWV/AIx/MAP/心率/糖尿病/高血压为自变量,输出平方和占比与 VIF;② 按 <40 / 40-59 / ≥60 分三档建模,检验 PWV 系数在档间是否衰减;③ 增量解释力检验——模型 A(年龄+性别+MAP+心率)→ 模型 B(+PWV+AIx),比 ΔR² 与 AIC,这是全篇最核心的一个数;④ 在残差谱上做糖尿病/高血压逐阶比较,10 阶 Bonferroni 阈值 0.005。

判读口径事先定死:ΔR²≥15% 且 VIF<3 → 硬化解释力真实;5-15% → 部分真实,须按年龄分层;<5% → 读的是年龄不是硬化,”抗硬化”话术须撤回。疾病信号方面:校正后仍有≥2 阶、方向一致、且在同病不同并发症间呈剂量-反应,方可称”疾病指纹”,否则只能叫”未解释残差”。

这套设计不打算证明脉诊有用。它的价值在于把”脉象反映血管老化”这句含糊话拆成两个能分别回答的问题:老化占多少,疾病占多少。 若答案是”老化占九成”,脉诊的临床定位就该是”血管年龄计”,而非”疾病探测器”。

证据与局限

已验证: 年龄是健康人群动脉硬化的最主要相关因素,模型 R²=0.512(PMID 15123572);糖尿病改写血管老化速率,较早达功能平台,校正血压后 PWV 与年龄不再相关(PMID 12832325);年龄、性别、平均动脉压、糖尿病对 PWV 各自独立相关(PMID 16855622);PWV 的年龄-性别-地区参照值差异显著,绝对值不可跨人群套用(PMID 37229905);年龄改写主动脉波形的主通道是储器压力(9.9 mmHg/十年,r=0.69)而非后向反射波(PMID 20008272);2 型糖尿病人群中波形形状的独立决定因素是 MAP、心率、身高,HbA1c 非独立(PMID 18497469);通用传递函数的校准误差有 76% 传入中心动脉压估计(PMID 16229910)。

部分验证: “控制年龄后 PWV/AIx 对谐波谱解释力保留多少”这一 ΔR² 数值尚无直接研究;现有证据只证明年龄与硬化各自独立、糖尿病改写年龄斜率,但两者方差在谐波谱上的分配比例是空白。糖尿病是否携带独立于硬化的谐波信号只有间接线索(AIx 在糖尿病组未达显著、在非糖尿病心血管病组显著,PMID 19888415),尚无控制硬化后的逐阶比较。

待验证: ① 控制年龄与 PWV/AIx 后,逐阶谐波能量比在糖尿病/高血压组是否仍有稳定偏移;② 该偏移是否在同病不同并发症亚组间呈剂量-反应(特异性的必要条件);③ 若 ΔR²<5%,”谐波谱=血管年龄计”这一降级表述能否获独立样本验证。

相关阅读

证据等级: B
参考文献: PMID 12832325, PMID 15123572, PMID 16855622, PMID 37229905, PMID 20008272, PMID 18497469, PMID 19888415, PMID 16229910


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

Old Age and Illness Are Two Separate Accounts: Stripping Age from Disease Leaves the Harmonic Spectrum with Reduced Explanatory Power

Evidence level: B

A healthy 65-year-old and a 45-year-old with 10 years of diabetes may present with remarkably similar pulse waveforms. However, “aging” and “disease” are two completely distinct accounts—separating them is crucial; otherwise, all prior conclusions regarding “hardening → harmonic spectrum” rest on a flawed foundation.

Main Text

The previous article brought “hardening/afterload” into the open: a substantial portion of the variance in pulse waveform harmonics can be explained by PWV (pulse wave velocity) and AIx (augmentation index). However, this conclusion relies on a critical default assumption: Are changes in PWV and AIx driven by aging, or by disease?

This is not academic nitpicking. The Framingham Offspring Cohort (188 men, 333 women; excluding clinical cardiovascular disease, hypertension, diabetes, smoking, and obesity) demonstrated that “age increase” is the primary correlate of elevated carotifemoral PWV, with a model R²=0.512 (PMID 15123572). Even in a purified sample free of hypertension and diabetes, hardening still rises with age. Therefore, comparing young people as a healthy group against an elderly diabetic group means that a significant portion of the observed “diabetes-induced hardening” is merely “the diabetic group being older on average.”

More problematic is that this confounding is not an additive offset but a rewritten slope. Cameron et al. measured PWV in three arteries across 169 participants (57 with diabetes, 112 without); the diabetic group showed faster PWV and lower central arterial compliance (0.662 vs 0.850, P<0.05), but averaged 10 years younger than the control group; furthermore, after adjusting for blood pressure, PWV showed no correlation with age in the diabetic group (PMID 12832325). The authors termed this “accelerated aging at an earlier age, followed by reaching a functional plateau”—in the diabetic population, the regression line linking “age → hardening” is flat. Calculating a “vascular age” for their PWV values using healthy reference tables has no physiological meaning.

So, what proportion is attributable to each? Alecu et al. performed multivariate regression on 221 apparent healthy individuals over 60, finding that PWV correlated independently with age, sex, mean arterial pressure, and diabetes (PMID 16855622). “Independently” indicates statistical separability, but it is far from a clean separation—both share the same downstream pathway (elastin fragmentation, collagen cross-linking, accumulation of advanced glycation end-products).

A 2023 systematic review including 167 studies, 509,743 participants across 34 countries, provided age-sex reference values for PWV (PMID 37229905): the same PWV value carries vastly different meanings across different ages, sexes, and regions (Asian baPWV is 1.83 m/s higher than European values, P=0.0014). Any absolute threshold without stratification is incorrect.

The question thus refines to: After controlling for age, how much explanatory power remains for PWV/AIx in the harmonic spectrum? Do diabetes and hypertension carry harmonic signals independent of hardening? All three outcomes are informative:

Outcome 1 (Erosion): If ΔR² drops below 5%—the primary association previously attributed to age is actually aging masquerading as hardening—the reading of “harmonic spectrum reflects vascular hardness” must be downgraded to “reads vascular age.”
Outcome 2 (Retention): If ΔR² remains above 15% with VIF<3, then “hardening independent of age rewrites the harmonic spectrum” holds water, allowing further decomposition of which harmonics are managed by AIx and which by PWV.
Outcome 3 (Disease Carries Independent Signal): If, after controlling for age and PWV, the diabetic or hypertensive groups still show shifts at specific harmonic orders—this is the most valuable cell, implying a disease fingerprint unexplainable by hardening within the harmonic spectrum, potentially arising from microcirculatory resistance, autonomic tone, or blood viscosity. The physical grounding for “same disease, different pulse; different disease, same pulse” lies here.

Pitfall 1: Using “Vascular Age” as a Covariate. Since vascular age is calculated from PWV and age, using it as a covariate mixes back the very elements meant to be separated. One must use raw PWV + age as two independent covariates.

Pitfall 2: Sample Collapse After Age Stratification. The prevalence of diabetes is naturally higher in the elderly group; strict stratification may leave some cells with very few subjects. An alternative is propensity score 1:1 matching based on age, sex, BMI, blood pressure, and heart rate, or treating age as a restricted cubic spline (the relationship between age and hardening is explicitly nonlinear; Uejima et al. found age explained 53% of the variance in carotid elastic modulus in 1,847 healthy individuals, with a significantly steeper slope in the elderly segment).

Pitfall 3: Reading “Unexplained Residuals” as “Disease Fingerprints”. Differences remaining after controlling for age and PWV only indicate “not explained by these two,” not “explained by diabetes itself”—it could be medication, activity levels, or renal function. To claim specificity, one must perform dose-response testing within subgroups of same disease but different complications. A debunked optimistic idea worth noting: since both pathways involve hardening, shouldn’t we just measure PWV directly? Data does not support this. Tomita et al. performed stepwise regression in 194 type 2 diabetics; the independent determinants of radial AI were mean blood pressure (β=0.260), heart rate (β=−0.550), and height (β=−0.217), with HbA1c becoming non-significant after multivariate adjustment (PMID 18497469). Wilhelm et al. found AIx higher in 33 diabetics than controls (21.12% vs 19.84%) but not significant, whereas it was significantly elevated in 100 non-diabetic cardiovascular patients (26.00%, P<0.02) (PMID 19888415). The label “diabetes” itself has surprisingly weak explanatory power for waveform shape.

The stubbornness of age has physiological grounding. Davies et al. decomposed intraluminal augmentation pressure into forward wave, backward reflection wave, and reservoir pressure components; finding that when reservoir pressure is included, the contribution of the backward reflection wave is reduced by 64%, with reservoir pressure becoming the largest component and increasing by 9.9 mmHg per decade (r=0.69, P<0.001), while the backward wave no longer correlates with age (PMID 20008272). The main channel through which age rewrites the waveform is aortic reservoir capacity, not earlier return of reflection waves—controlling only for PWV misses this pathway, which is why both AIx and PWV must be collected simultaneously.

The final risk: Transfer function errors mistaken for physiological signals. Papaioannou et al. simulated calibration errors in 103 participants; a ±5 mmHg bias in isolated brachial systolic pressure transmitted 76% unchanged to the inferred central arterial pressure, with higher transmission ratios observed when mean pressure >117 mmHg or heart rate <74 bpm (PMID 16229910). Elderly diabetics fall precisely into the category of higher blood pressure and slower heart rate—the very groups with the highest error transmission rates being compared. Thus, this design mandates identical equipment and calibration, prioritizing measured radial artery waveforms for harmonic decomposition.

Four-step design: ① Full-sample Type III variance decomposition, with harmonic energy ratios (C1-C10) as the dependent variable and age/sex/PWV/AIx/MAP/heart rate/diabetes/hypertension as independent variables, outputting squared sum proportions and VIF; ② Modeling in three strata (<40 / 40-59 / ≥60) to test if PWV coefficients attenuate between strata; ③ Incremental explanatory power testing—Model A (age + sex + MAP + heart rate) → Model B (+PWV+AIx), comparing ΔR² with AIC; this is the single most core metric for the entire article; ④ Stepwise comparison of diabetes/hypertension in the residual spectrum, with a Bonferroni threshold of 0.005 for 10 orders.

Judgment criteria are fixed in advance: ΔR²≥15% and VIF<3 → genuine hardening explanatory power; 5-15% → partially true, requires age stratification; <5% → reading age not hardening, “anti-hardening” rhetoric must be withdrawn. Regarding disease signals: only if ≥2 harmonics remain significant post-adjustment, with consistent direction and a dose-response relationship across same-disease different-complication subgroups can it be termed a “disease fingerprint”; otherwise, it is merely “unexplained residual.”

This design does not aim to prove pulse diagnosis is useful. Its value lies in deconstructing the vague statement “pulse reflects vascular aging” into two answerable questions: how much is aging, and how much is disease. If the answer is “aging accounts for 90%,” the clinical positioning of pulse diagnosis should be “vascular age meter,” not “disease detector.”

Evidence and Limitations

Verified: Age is the primary correlate of arterial hardening in healthy populations, model R²=0.512 (PMID 15123572); diabetes rewrites vascular aging rate, reaching functional plateau earlier, and PWV correlates with age no longer after blood pressure adjustment (PMID 12832325); age, sex, mean arterial pressure, and diabetes correlate independently with PWV (PMID 16855622); age-sex-region reference values for PWV show significant differences, making absolute values unsuitable across populations (PMID 37229905); age rewrites the main channel of aortic waveform via reservoir pressure (9.9 mmHg/decade, r=0.69) rather than backward reflection waves (PMID 20008272); in type 2 diabetes, independent determinants of waveform shape are MAP, heart rate, and height, with HbA1c non-independent (PMID 18497469); general transfer function calibration errors transmit 76% into central arterial pressure estimates (PMID 16229910).

Partially Verified: The ΔR² value regarding “how much explanatory power PWV/AIx retains in the harmonic spectrum after controlling for age” lacks direct research; existing evidence only proves independent correlation of age and hardening, and that diabetes rewrites the age slope, but the allocation proportion of their variance in the harmonic spectrum is blank. Whether diabetes carries harmonic signals independent of hardening offers only indirect clues (AIx not significant in diabetic group but significant in non-diabetic cardiovascular patients, PMID 19888415), lacking stepwise comparison after controlling for hardening.

To Be Verified: ① After controlling for age and PWV/AIx, whether harmonic energy ratios still show stable shifts in diabetic/hypertensive groups at each order; ② Whether such shifts exhibit a dose-response relationship across subgroups of same disease but different complications (a necessary condition for specificity); ③ Whether the downgraded statement “harmonic spectrum = vascular age meter” can be validated in an independent sample if ΔR²<5%.

Related Reading

Evidence Level: B
References: PMID 12832325, PMID 15123572, PMID 16855622, PMID 37229905, PMID 20008272, PMID 18497469, PMID 19888415, PMID 16229910


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *